Boston, MA -- (SBWIRE) -- 06/27/2017 -- Lymphoma is a type of cancer that affects the immune system of the body. Specifically, it affects the lymphocytes, a type of white blood cell. The lymphocytes are part of the immune system and help the body to fight infections. The cancerous lymphocytes grow uncontrollably and collect in different portions of the body; lymph node can be one of the most common sites for lymphoma development. The lymph nodes are found throughout the body particularly in the groin, neck, and under the arms. Lymphoma can also develop in the deeper lymph nodes such as those in bone marrow and spleen. Very rarely this disease can start in other parts of the body such as stomach, breast, skin, brain, bowel, or liver.

Get More Details on this Report and a Full Table of Contents at Global Lymphoma Drugs Market 2017-2021

Technavio's analysts forecast the global lymphoma drugs market to grow at a CAGR of 8.02% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global lymphoma drugs market for 2017-2021. To calculate the market size, the report considers the sales from branded, generic, and off-label drugs.

The market is divided into the following segments based on geography:

-Americas
-APAC
-EMEA

Technavio's report, Global Lymphoma Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

-Celgene
-F. Hoffmann-La Roche
-Johnson & Johnson
-Seattle Genetics

Other prominent vendors

-Amgen
-Bristol-Myers Squibb
-Gilead Sciences
-GlaxoSmithKline
-Novartis
-Pfizer
-Takeda Pharmaceuticals
-Teva Pharmaceutical Industries

Market driver

-Increase in industry-academia collaborations
-For a full, detailed list, view our report

Market challenge

-High cost of lymphoma treatment
-For a full, detailed list, view our report

Market trend

-Increasing consolidation in the cancer treatment market
-For a full, detailed list, view our report

Key questions answered in this report

-What will the market size be in 2021 and what will the growth rate be?
-What are the key market trends?
-What is driving this market?
-What are the challenges to market growth?
-Who are the key vendors in this market space?
-What are the market opportunities and threats faced by the key vendors?
-What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Companies Mentioned in this Report: Celgene, F. Hoffmann-La Roche, Johnson & Johnson, Seattle Genetics, Amgen, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Novartis, Pfizer, Takeda Pharmaceuticals, Teva Pharmaceutical Industries

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

-Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016
-B-Cell Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016
-Angioimmunoblastic T-Cell Lymphoma (AILT)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2016
-Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016
-Anaplastic Large Cell Lymphoma (ALCL) Global Clinical Trials Review, H1, 2016